ICMR-NICED proposes research on oral COVID vaccine

Kolkata-based ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral COVID vaccine, a senior official of the institute said on Monday.

The proposed research project will be done in collaboration with a German firm and it has been shortlisted for presentation, she said.

“We have submitted a proposal for research on an oral vaccine. It will be carried out in collaboration with a German firm. Work can be started once it gets selected and funded,” ICMR-NICED Director Shanta Dutta said.

She said it will take around 5-6 years to develop the oral vaccine in a laboratory.

Once the oral vaccine is developed, it will first be tested on animals as is done for all vaccines, Dutta said.

“All stages of developing a vaccine, and phases of clinical trials for safety and immunogenicity will be followed in this case too and the vaccine will be first tested on animals.

“The entire process will take at least five to six years and we can expect the oral vaccine in the market only after that,” she added.

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise